James analyst Dane Leone maintained a Strong Buy rating and a $19.00 price target on Ocular Therapeutix (NASDAQ:OCUL), aligning with the broader analyst consensus. According to InvestingPro data, ...

Idex maintains a sound capital structure. As of Dec. 31, 2024, the firm owed roughly $2 billion in short- and long-term debt while holding approximately $0.6 billion in cash and cash equivalents.

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

Champion Homes Inc. reported strong financial results for the third quarter of 2024, surpassing Wall Street expectations. The company's earnings per share (EPS) were $1.06, beating the forecast of $0.

In recent years, many investors have shifted their focus from dividend-paying stocks to high-growth secular-themed stocks that typically don’t offer dividends.

Net sales for the 2025 first quarter increased $47.9 million, or 18.7 percent, to $304.3 million as compared with $256.4 million in the prior year quarter primarily due to increased volumes at Water ...

A better-than-expected quarterly print from Palantir Technologies Inc. has resulted in a massive after-hours pop in its stock ...

NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the fourth quarter and full-year, which ended December 31, 2024. “NXP delivered full-year 2024 revenue of $12.61 billion, a ...

The Cincinnati Reds traded from their pitching depth on Monday, sending right-hander Casey Legumina to the Seattle Mariners.

Universities in Wales face a £70m black hole amid warnings that there is further gloom to come. The collective deficit of ...

Women's health is not getting enough funding despite First Minister Eluned Morgan making it a top priority, politicians have ...

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops ...